March 9, 2026

AstraZeneca PLC (AZN) Stock Analysis: Evaluating Growth Potential with a 22.84% ROE

AstraZeneca PLC (AZN) remains a formidable player in the global healthcare sector, with its expansive portfolio of prescription medicines targeting a wide array of diseases. Based in Cambridge, UK, AstraZeneca..

Fresenius Medical Care AG (FMS) Stock Analysis: Uncovering an 18.45% Potential Upside Amidst Industry Challenges

Fresenius Medical Care AG (NYSE: FMS) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Bad Homburg, Germany, the company is..

Zoetis Inc. (ZTS) Stock Analysis: A 24.35% Potential Upside in the Animal Health Sector

Investors looking for growth opportunities in the healthcare sector may want to take a closer look at Zoetis Inc. (NYSE: ZTS). As a leader in the animal health industry, Zoetis..

Cardinal Health, Inc. (CAH) Stock Analysis: A Healthcare Giant with 14.46% Potential Upside

Cardinal Health, Inc. (NYSE: CAH) stands as a formidable player in the healthcare sector, particularly within the medical distribution industry. With a robust market capitalization of $51.25 billion, the company..

STERIS plc (STE) Stock Analysis: 22% Potential Upside Amid Robust Revenue Growth

STERIS plc (NYSE: STE), a prominent player in the healthcare sector, is capturing investor attention with a promising potential upside of 22.01%. With a market capitalization of $22.62 billion, STERIS..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A Biotech Powerhouse with 42% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading player in the biotechnology sector, continues to captivate investor interest with its innovative approach to therapeutics. This Cambridge, Massachusetts-based company specializes in the..

Medtronic plc (MDT) Stock Analysis: Exploring a 22.87% Upside Potential

Medtronic plc (MDT) stands as a formidable entity in the healthcare sector, specifically within the medical devices industry. Headquartered in Galway, Ireland, Medtronic boasts a market capitalization of $116.71 billion,..

Danaher Corporation (DHR) Stock Analysis: Unveiling a 35.50% Upside Potential Amidst Robust Analyst Support

For those keeping a close eye on the healthcare sector, Danaher Corporation (NYSE: DHR) represents a compelling investment option. With a market capitalization of $138.25 billion, Danaher is a heavyweight..

HCA Healthcare (HCA) Stock Analysis: Evaluating Growth in a Competitive Healthcare Sector

Investors eyeing the healthcare sector for stable and potentially lucrative opportunities may find HCA Healthcare, Inc. (NYSE: HCA) a compelling case study. With a market capitalization of $119.15 billion, HCA..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Analyst Consensus Points to a 35% Upside

For investors eyeing the healthcare sector, IQVIA Holdings, Inc. (NYSE: IQV) stands out as a formidable player within the diagnostics and research industry. Based in Durham, North Carolina, IQVIA offers..

ResMed Inc. (RMD) Stock Analysis: Navigating the Healthcare Sector with a 17.64% Upside Potential

ResMed Inc. (RMD), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers intriguing prospects for investors. With a market capitalization of $36.91 billion,..

Mettler-Toledo International (MTD) Stock Analysis: Unpacking a 24% Potential Upside with Diagnostic Precision

Mettler-Toledo International Inc. (NYSE: MTD) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $24.71 billion, this Swiss-based..

Sanofi (SNY) Stock Analysis: Exploring a Potential 29.47% Upside in the Healthcare Giant

Sanofi (SNY), a leading player in the healthcare sector, is capturing investor attention with a promising potential upside of 29.47%. With a market capitalization of $107.59 billion, this Paris-based pharmaceutical..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant with a 14% Upside Potential

Cencora, Inc. (NYSE: COR), a formidable player in the healthcare sector, has caught the attention of investors with its robust market presence and potential for significant upside. As a leader..

Boston Scientific Corporation (BSX) Stock Analysis: Unpacking a 46.10% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a titan in the medical devices industry, stands out with a striking potential upside of 46.10%, capturing investor attention. With its market cap soaring at..

Stryker Corporation (SYK) Stock Analysis: Exploring a 16.55% Potential Upside in the Medical Device Sector

Stryker Corporation (SYK), a prominent player in the healthcare sector, primarily focuses on medical devices. With a market capitalization of $139.51 billion, Stryker stands as a formidable force in the..

Eli Lilly and Company (LLY) Stock Analysis: Unveiling a 22.62% Potential Upside

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, continues to capture the attention of investors with its promising growth prospects and significant market presence. With a..

Merck & Company (MRK) Stock Analysis: Strong Growth Potential with a 9.87% Upside

Merck & Company, Inc. (NYSE: MRK) stands as a formidable entity in the global healthcare sector, with its roots deeply entrenched in the drug manufacturing industry. As of its latest..

Novo Nordisk A/S (NVO) Stock Analysis: Navigating a 25% Upside in the Healthcare Sector

Novo Nordisk A/S (NVO), a stalwart in the healthcare sector, holds a commanding presence in the drug manufacturing industry with a focus on diabetes and obesity care, as well as..

Diversified Energy sharpens its playbook as acquisitions reshape the cash flow profile

Diversified Energy outlined record 2025 results and a further East Texas gas acquisition that reinforces its low-decline, cash generation strategy...
Search

Funds

March 9, 2026

Diversified Energy sharpens its playbook as acquisitions reshape the cash flow profile

Diversified Energy outlined record 2025 results and a further East Texas gas acquisition that reinforces its low-decline, cash generation strategy...
Search

Funds

March 9, 2026

FTSE 100

Funds